Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › LPAAT-β inhibitors and uses thereof

LPAAT-β inhibitors and uses thereof

US Patent 7608620 · Granted Oct 27, 2009

Estimated economic value: $37,673,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-glyco-MUC1 antibodies and their uses2025
Anti-glyco-MUC1 antibodies and their uses2024
Anti-glyco-MUC1 antibodies and their uses2021
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d2018
Manufacturing process for pyrimidine derivatives2016
Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)2016
Compounds for the treatment of conditions associated with DGAT1 activity2016
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-D2015
Compounds for the treatment of conditions associated with DGAT1 activity2015
Conjugates of biologically active polypeptides having an increased in vivo half-2014
Conjugates of biologically active proteins having a modified in vivo half-life2012
Aryl triazines as LPAAT-β inhibitors and uses thereof2009